Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich

Cat. No.EK11F897

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine Cardiac Phospholamban (PLN) ELISA Kit-Sandwich is designed for the quantitative determination of Bovine Cardiac Phospholamban (PLN) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine PLN.
Target Species Bovine
Species Reactivity Bovine
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 270 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Bovine Cardiac Phospholamban is encoded by the PLN gene in cattle. It plays a crucial role in the regulation of cardiac muscle contraction. It is a key component of the sarcoplasmic reticulum (SR) and regulates the activity of the SERCA2a. It is a also critical player in maintaining calcium homeostasis in the heart, impacting muscle contraction and overall cardiac function.

Target/Biomarker Bovine PLN
Target Synonym phospholamban; PLB; cardiac phospholamban
Gene ID 100125240
UniProt ID A4IFH6

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. te Rijdt, W. P. et al. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST). Netherlands Heart Journal. 2022, 30: 84-95.
Inquiry Basket